[go: up one dir, main page]

SMT201800488T1 - Formulazioni stabilizzate contenenti anticorpi anti-recettore interleuchina-4 (il-4r) - Google Patents

Formulazioni stabilizzate contenenti anticorpi anti-recettore interleuchina-4 (il-4r)

Info

Publication number
SMT201800488T1
SMT201800488T1 SM20180488T SMT201800488T SMT201800488T1 SM T201800488 T1 SMT201800488 T1 SM T201800488T1 SM 20180488 T SM20180488 T SM 20180488T SM T201800488 T SMT201800488 T SM T201800488T SM T201800488 T1 SMT201800488 T1 SM T201800488T1
Authority
SM
San Marino
Prior art keywords
interleukin
antibodies
receptor
formulations containing
containing anti
Prior art date
Application number
SM20180488T
Other languages
English (en)
Italian (it)
Inventor
Daniel B Dix
Xiaolin Tang
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Priority claimed from EP11770625.9A external-priority patent/EP2624865B1/en
Publication of SMT201800488T1 publication Critical patent/SMT201800488T1/it

Links

SM20180488T 2010-10-06 2011-10-05 Formulazioni stabilizzate contenenti anticorpi anti-recettore interleuchina-4 (il-4r) SMT201800488T1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39028310P 2010-10-06 2010-10-06
EP11770625.9A EP2624865B1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
PCT/US2011/054856 WO2012047954A1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Publications (1)

Publication Number Publication Date
SMT201800488T1 true SMT201800488T1 (it) 2018-11-09

Family

ID=45995014

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20180488T SMT201800488T1 (it) 2010-10-06 2011-10-05 Formulazioni stabilizzate contenenti anticorpi anti-recettore interleuchina-4 (il-4r)

Country Status (14)

Country Link
AR (1) AR083338A1 (zh)
DK (2) DK2624865T3 (zh)
ES (2) ES2820246T3 (zh)
HK (1) HK1258305A1 (zh)
HR (1) HRP20181822T1 (zh)
HU (1) HUE052089T2 (zh)
LT (1) LT2624865T (zh)
PT (1) PT3354280T (zh)
RS (1) RS57850B1 (zh)
SI (1) SI2624865T1 (zh)
SM (1) SMT201800488T1 (zh)
TW (7) TWI498121B (zh)
UA (1) UA111731C2 (zh)
UY (1) UY33652A (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015003590A8 (pt) 2012-08-21 2017-10-31 Sanofi Sa Métodos para tratamento ou prevenção da asma por administração de um antagonista de il-4r
HUE046410T2 (hu) * 2013-06-21 2020-03-30 Sanofi Biotechnology Eljárások orrpolipózis kezelésére IL-4R-antagonista beadásával
AU2014284235B2 (en) * 2013-06-21 2019-11-21 Regeneron Pharmaceuticals, Inc. Methods for treating nasal polyposis by administering an IL-4R antagonist
WO2016077675A1 (en) 2014-11-14 2016-05-19 Sanofi Biotechnology Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist
PL3703818T3 (pl) 2017-10-30 2024-03-25 Sanofi Biotechnology Antagonista IL-4R do zastosowania w sposobie leczenia lub zapobiegania astmie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
ES2332082B1 (es) * 2008-07-24 2010-10-26 Consejo Superior De Investigaciones Cientificas (Csic) 45% Sistema de alineacion de patrones en un sustrato mediante litografia por estencil.
KR101593726B1 (ko) * 2008-09-10 2016-02-18 니혼 엑스란 고교 (주) 가교 아크릴레이트계 섬유 및 이의 제조방법
CA2754528A1 (en) * 2009-03-06 2010-09-10 Genetech, Inc. Antibody formulation

Also Published As

Publication number Publication date
HK1258305A1 (zh) 2019-11-08
TW201716086A (zh) 2017-05-16
TW202320851A (zh) 2023-06-01
PT3354280T (pt) 2020-09-01
HUE052089T2 (hu) 2021-04-28
DK3354280T3 (da) 2020-09-28
TW202026011A (zh) 2020-07-16
TWI690329B (zh) 2020-04-11
TW202102262A (zh) 2021-01-16
UY33652A (es) 2012-04-30
TWI856388B (zh) 2024-09-21
TW201221141A (en) 2012-06-01
RS57850B1 (sr) 2018-12-31
ES2687813T3 (es) 2018-10-29
HRP20181822T1 (hr) 2018-12-28
ES2820246T3 (es) 2021-04-20
TWI718890B (zh) 2021-02-11
TW201542229A (zh) 2015-11-16
TWI498121B (zh) 2015-09-01
TWI782325B (zh) 2022-11-01
SI2624865T1 (sl) 2018-10-30
TWI679988B (zh) 2019-12-21
DK2624865T3 (en) 2018-10-22
TW201924718A (zh) 2019-07-01
AR083338A1 (es) 2013-02-21
LT2624865T (lt) 2018-10-25
UA111731C2 (uk) 2016-06-10
TWI568445B (zh) 2017-02-01

Similar Documents

Publication Publication Date Title
IL283424B1 (en) Stabilized formulations that include antibodies against the interleukin receptor (il-4r)
HRP20181821T1 (hr) Stabilizirani pripravci koji sadrže anti-interleukin-6 receptorska (il-6r) antitijela
IL265501B (en) Stabilized liquid formulations containing antibody
SI3409289T1 (sl) Stabilni sestavki, ki vsebujejo protitelo
HK1258305A1 (zh) 含有抗白介素-4受體(il-4r)的抗體的穩定製劑
EP2588141A4 (en) ANTIBODY FORMULATIONS